Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma

BACKGROUND: T cell receptor (TCR)-T cells possess similar effector function, but milder and more durable signal activation compared with chimeric antigen receptor-T cells. TCR-T cell therapy is another active field of cellular immunotherapy for cancer. METHODS: We previously developed a human anti-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenggong, Zhou, Fen, Wang, Jing, Chang, Qi, Du, Mengyi, Luo, Wenjing, Zhang, Yinqiang, Xu, Jia, Tang, Lu, Jiang, Huiwen, Liu, Lin, Kou, Haiming, Lu, Cong, Liao, Danying, Wu, Jianghua, Wei, Qiuzhe, Ke, Sha, Deng, Jun, Liu, Cheng, Mei, Heng, Hu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862812/
https://www.ncbi.nlm.nih.gov/pubmed/36681817
http://dx.doi.org/10.1186/s13045-023-01402-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862812/
https://www.ncbi.nlm.nih.gov/pubmed/36681817
http://dx.doi.org/10.1186/s13045-023-01402-y

Ejemplares similares